News
New weight loss pill could benefit people with Type 2 diabetes: Drugmaker
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels on average by 1.3-1.6% and also help people lose up to 16 pounds, or about 7.9% of their body weight.
A new study finds two groups of additives in processed foods may increase type 2 diabetes risk. Here, experts explain the ...
New research finds that having unmanaged type 2 diabetes can cause similar symptoms to early Alzheimer's disease. Here's what ...
They were originally developed to treat type 2 diabetes, which happens when the body’s cells become resistant to the ...
According to the NHS website, type 2 diabetes symptoms include peeing more than usual, feeling very tired, feeling thirsty ...
A once-daily oral GLP-1 conferred greater reductions in HbA1c and body weight than placebo among adults with type 2 diabetes, ...
The following is a summary of “Referral reasons of type 2 diabetes patients from general practitioners to diabetes specialists: a cross-sectional observational study,” published in the April 2025 ...
Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist, significantly reduced hemoglobin A1c (HbA1c) in adults with type 2 diabetes (T2D) and inadequate glycemic control with diet ...
However, clusters of additives often used by industry in certain food categories may be more harmful when eaten together than ...
Type 2 diabetes is a lifelong condition that can be put into remission — the foods we eat can have an important effect ...
The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback